TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

about

Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer.Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

P2860

Q55225241-9A92090B-402C-425C-A117-926B91F7AF46 Q57072897-6E499CC1-308C-49E8-A61C-DFDE543242B4

P2860

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

Item

http://www.wikidata.org/entity/Q47127243

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

@en

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer

@nl

type

Item

label

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

@en

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer

@nl

prefLabel

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

@en

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer

@nl

P1476

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

@en

P2093

Bingbing Dai

http://www.w3.org/2001/XMLSchema#string

Emanuela Gentile

http://www.w3.org/2001/XMLSchema#string

Ismail Meraz

http://www.w3.org/2001/XMLSchema#string

Jack A Roth

http://www.w3.org/2001/XMLSchema#string

Jing Lin

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Lin Ji

http://www.w3.org/2001/XMLSchema#string

Mourad Majidi

http://www.w3.org/2001/XMLSchema#string

Shuhong Wu

http://www.w3.org/2001/XMLSchema#string

Xiaobo Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in Autophagy Regulatory Mechanisms

Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans

The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Immunoregulatory functions of mTOR inhibition.

HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.

An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.

Therapy-induced tumour secretomes promote resistance and tumour progression

P304

107621-107629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22581

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296193

http://www.w3.org/2001/XMLSchema#string

P932

5746095

http://www.w3.org/2001/XMLSchema#string

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

about

P2860

P2860

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932